Nephrotoxic Biomarkers with Specific Indications for Metallic Pollutants: Implications for Environmental Health
Abstract
Environmental and occupational exposure to heavy metals and metalloids is a major global health risk. The kidney is often a site of early damage. Nephrotoxicity is both a major consequence of heavy metal exposure and potentially an early warning of greater damage. A paradigm shift occurred at the beginning of the 21st century in the field of renal medicine. The medical model of kidney failure and treatment began to give way to a social model of risk factors and prevention with important implications for environmental health. This development threw into focus the need for better biomarkers: markers of exposure to known nephrotoxins; markers of early damage for diagnosis and prevention; markers of disease development for intervention and choice of therapy. Constituents of electronic waste, e-waste or e-pollution, such as cadmium (Cd), lead (Pb), mercury (HG), arsenic (As) and silica (SiO2) are all potential nephrotoxins; they target the renal proximal tubules through distinct pathways. Different nephrotoxic biomarkers offer the possibility of identifying exposure to individual pollutants. In this review, a selection of prominent urinary markers of tubule damage is considered as potential tools for identifying environmental exposure to some key metallic pollutants.
Introduction
It is predicted that electronic waste (e-waste)1 will reach 74 million metric tonnes by 2030, making this the world’s fastest-growing domestic waste stream. In addition to the growing threat of e-wastes, urbanisation and industrialisation have contributed to metal contamination in the environment in low-income countries adversely affecting human health.2 Among the possible sources of contamination are soil, dust and food matrices.2-4 Drinking water contaminated with heavy metals such as arsenic (As), cadmium (Cd), mercury (Hg) and lead (Pb) is a major health concern.5 In 2012 The World Health Organisation (WHO)6 reported that preventable environmental risks accounted for 12.6 million deaths worldwide. In 2015 the estimated global anthropogenic mercury (Hg) release was approximately 1800 tonnes.7 Hg and methylmercury are major pollutants of the environment and exposure can be via food, mining or due to contamination of water supplies.8 According to the WHO, at least 140 million people in 50 countries have been drinking water containing arsenic (As) at levels above the WHO provisional guidelines.9 The primary sources of As toxicity in the general population is contaminated water, soil and food products.10 Commercial production of Cd rose throughout the 20th century and now fluctuates around 23 000 metric tonnes annually. The manufacture of Cd/Nickel batteries accounts for around 55% of this and it is expanding because of the greater demand for rechargeable batteries. Environmental levels of Pb have increased because of the use of leaded fuel, Pb-based paint, mining, plumbing and other industrial activities.11 Pb is one of the most widely occurring divalent metals that induce nephrotoxicity, and this has been demonstrated even at low doses.12 In addition to respiratory diseases silica causes kidney damage. As well as being part of e-waste, the rapid emergence of silica nanoparticles for drug delivery threatens to markedly increase the risk of silica-induced nephrotoxicity.1 Exposure to pollutants present in waste is a common cause of kidney disease which is most prominent in, but not restricted to, developing countries. The kidney is particularly susceptible to environmental pollutants and following exposure, levels of circulating pollutants in blood rise. The kidney filtres approximately 180 L of blood per day, producing approximately 1.8 L of urine. The result is a high renal exposure to pollutants. A recent review13 highlighted the epidemiological evidence for the association between both acute and chronic kidney disease, with environmental pollutants, including air pollution, heavy metal pollution and other environmental risk factors. The measurement of urinary biomarkers plays an increasingly important role in the monitoring of at-risk populations from exposure to heavy metals and metalloids.
In this review, we discuss the advent and principles of new biomarkers of nephrotoxicity with an in-depth focus on the most prominent entering use. To assess the potential utility of the biomarkers in environmental studies, we offer an overview of the methodologies used in their measurement. We then consider the mechanism of nephrotoxic damage and the evidence for biomarkers to detect the damage caused, by cadmium (Cd), mercury (Hg), lead (Pb), arsenic (As) and silica (SiO2).
Biomarkers
The use of biomarkers in the detection of acute kidney injury has increased substantially in the last 10 years. The number of publications retrieved from Pubmed using the search term ‘biomarker’ has increased 1.7-fold between 2009 and 2019, the number retrieved for ‘biomarker’ and ‘nephrotoxicity’ has increased 3.9-fold and for ‘biomarker’ and ‘Acute Kidney Injury’ the increase over the same period was 6.9-fold, more than fourfold greater than biomarkers in general (Figure 1).
Human kidneys have the potential to suffer significant impairment of function without obvious manifestation of symptoms. Biomarkers are therefore required for early detection of exposure to environmental nephrotoxins13 present in soil, dust, water, food and air.14 This information can be used to help to limit the adverse renal effects. Biomarkers should be objective measures of biological and pathogenic processes. Common and almost universally accepted renal biomarkers such as serum creatinine (sCr), blood urea nitrogen (BUN) and urinary albumin Alb/creatinine ratio (ACR) have proved to be insensitive and inadequately specific.15 Many alternative tentative urinary biomarkers have been reported in the literature16-19 of these 2 biomarkers, β2-microglobulin (β2-MG) and N-acetyl-β-D-glucosaminidase (NAG) have gained widespread use in the environmental field. Kidney injury molecule-1 (KIM-1) and neutrophil gelatinase associated lipocalin (NGAL) which are up-regulated in the renal proximal tubules are widely used to monitor the progression of acute kidney disease in clinical research. Both these biomarkers are now gaining ground in the environmental research field. Further information can be obtained from Wasung et al,18 who reviewed a range of potential biomarkers of renal function used in monitoring the progression of acute kidney injury (AKI) and chronic kidney disease (CKD). An in-depth review considered the value of urine and serum biomarkers for the detection of AKI.19
β2-MG is a low molecular mass protein filtered by the glomeruli and normally reabsorbed in the renal tubules. In common with other low molecular weight proteins, β2-MG is virtually completely reabsorbed by megalin-mediated endocytosis in the proximal tubules and subsequently catabolised within the tubular cell. Under pathological conditions, β2-MG appears in the urine indicating kidney injury.18 Although still frequently used, β2-MG is being replaced by other markers because of its instability in urine at pH < 7. However as partial degradation occurs before voiding has made it less reliable.20 Evidence suggests that even when urine is stored at −80°C degradation reduced measured β2-MG activity after only 6 hours.21 Data from a clinical study22 indicated that urinary β2-MG is a good biomarker for proximal tubular injury. When the urine samples are collected from patients the pH requires adjustment to pH 6 to 8 with sodium hydroxide before overnight shipping to the laboratory for assay. This additional step could prove to be a disadvantage in studies where large numbers of the population are screened. Further, it was demonstrated23 that β2-MG is rapidly degraded in the bladder at low pH. An alternative procedure to avoid the deterioration of β2-MG in acidic urine involved instructing patients to take 400 mg of oral sodium bicarbonate the evening before the measurement of urinary β2-MG was carried out after ingestion of tap water to enforce diuresis.24 However, the need for these preliminary steps would make it difficult to apply to large populations in the environmental situation. In experiments25 designed to define the extent, variability, and the mechanism of its instability in urine at pH 6 it was found that this was eliminated by heating to 80°C, a temperature that eliminates any enzymes present. This result suggests that the instability may be a consequence of enzyme activity. In an earlier study,26 it was concluded that urinary retinal binding protein (RBP) was a better marker than β2-MG because of its greater stability in urine and independence of pH. In a study comparing NAG and β2-MG urinary activities in 1 month to 3-year-old babies, it was found27 that the 3-month-old group had lower levels than the 12 months and 3-year-old groups. Interestingly the NAG values were almost constant throughout the 3 years. Since urine pH is easily affected by diet and children consume milk as the main part of their diet the decrease in β2-MG activity may be explained as an effect of the proteins in milk. An association between urine pH and age in young infants was reported.28 Data from a later study29 suggested that β2-MG may be a better marker of glomerular rather than tubular injury.
NAG is a lysosomal enzyme widely distributed in human tissue. It is released into serum from cells by exocytosis or from the breakdown of cells. The molecular weight of NAG is between 130 and 140 kDa preventing its filtration through the glomerulus although it is routinely cleared by the liver. The release of lysosomal hydrolases including NAG into the urine from the renal proximal tubules indicates tubular damage. The damage may be a result of either exposure to nephrotoxic agents including heavy metals such as Cd,30,31 or other renal tubular abnormalities. NAG is the most active enzyme among proximal tubular lysosomal glycosidases, it is stable in urine and as a result, NAG is one of the most widely used biomarkers of renal tubular injury.32-34 It is also used routinely as a reference test in assessing renal tubular injury in both humans and animal models.35,36
KIM-1 also named Hepatitis A virus cellular receptor 1 (HAVCR1) or T-cell immunoglobulin mucin receptor 1 (TIM1), is a multifunctional transmembrane protein. KIM-1 acts as an attachment receptor for a variety of virions and functions as a co-stimulatory molecule on T cells. In the kidney, KIM-1 is expressed in the s3 segment of the proximal tubule following injury. The extracellular domain is shed by a MAP kinase regulated process and its presence in urine correlates with its expression in the tissues.37
NGAL, also named Lipocalin-2 (LCN2), is stored in granules in neutrophils but also synthesised de novo by macrophages during inflammation. As a result of its size, 25 kDa together with its resistance to protease degradation, NGAL passes freely through the glomerulus and is retrieved via endocytosis in the proximal tubule. In man, NGAL expression can be stimulated in the Loop of Henle and the Collecting Duct.38
There are other biomarkers under investigation in clinical settings of kidney injury but they are used less widely for heavy metal toxicity screening (see Supplemental 1). In general, these tests measure proteins normally endocytosed by the proximal tubule, enzymes lost from damaged renal cells, markers of inflammation and more recently, micro-RNA. Biomarkers of failure of tubule reabsorption,33 indicate a functional deficit and include low molecular mass proteins include alpha 1 microglobulin, α1-MG; retinol binding protein, RBP; metallothionein, MT; cystatin C, Cys-C; Clara Cell Protein, CC16. Renal tubular enzymes released because of tubular injury include alkaline phosphatase, ALP; alpha-glutathione transferase, α-GST; glutathione-S-transferase Pi, π-GST; γ-glutamyl transpeptidase, GGT and lactic acid dehydrogenase, LDH. Acute kidney injury is also associated with the excretion of microRNAs for example, miR-21, miR-200c, miR-423.5,16,18,39,40 The number of novel urinary biomarkers tested to detect nephron segment specific injuries caused by heavy metals is increasing dynamically. The tissue specificity and early release of circulating miRNAs following tissue injury make them promising biomarkers of tissue injury.41 The recent epidemiological and toxicological advances in using miRNAs as biomarkers of chemical exposure in kidney damage have been reviewed.42
The use of multiple biomarkers has the potential to produce qualitative as well as quantitative information about nephrotoxic agents. Renal biomarkers are often the result of damage to a specific region of the kidney tubule carrying out a variety of different functions. This is illustrated in Figure 2, using NAG, KIM-1 and NGAL, as examples. Many small proteins are freely filtered by the glomerulus and reabsorbed in the proximal tubule for example NGAL which is taken up by megalin. Hence, the majority of urinary NGAL may be a result of a failure of megalin mediated endocytosis and reflects a functional problem predominantly in the s1 segment of the tubule. There remains some controversy over renal NGAL expression in different species. Megalin mediated endocytosis is one of the defining functions of the proximal tubule and its reduction or loss is seen as a key indicator of loss of function.
KIM-1 is expressed in the s3 segment of the proximal tubule, which is the most distal to the glomerulus, its expression is controlled at the transcriptional level by STAT3 (signal transducer and activator of transcription 3) transcription factor.37 The expression of KIM-1 is, therefore, mediated by toxins or stimuli activating this pathway. The presence of KIM-1 in urine depends on the cleavage of the cell surface molecule by matrix metalloproteinase enzymes expressed in the tubule. The presence of NAG in urine is a result of necrosis, necroptosis and ferroptosis and it is expressed in all 3 segments of the proximal tubule, s1 > s2 > s3 (Figure 2).
Urinary Biomarker Assay Methods
The sensitivity of any biomarker used in the detection of damage is dependent on the methods used to measure the biomarker. The measurement of urinary NAG activity has been quantified either spectrofluorimetrically or spectrophotometrically.43 The assay must be sufficiently sensitive to allow the dilution of the inhibitory effect of urea. Initially, the most widely used substrates were 4-methylumbelliferyl-N-acetyl-β-D-glucosaminide incorporating a fluorescent aglycone and the 4-nitrophenyl-N-acetyl-β-D-glucosaminide (PNP-GlcNAc) incorporating a chromogenic aglycone. More recently several novel colourimetric substrates (Table 1) with higher extinction coefficients and greater sensitivity have been developed.33,44 Both manual and automated assays have been used.44,45 Recently, kits utilising the 96 well plate absorbance readers have been widely used for testing across species. NAG activities and other urine enzyme activities need to be factored by urine creatinine to allow for the variation in urine flow. NAG activities are expressed as (µmol hydrolysed substrate/min × L urine) and or NAG indices (µmol hydrolysed substrate/min × mmol creatinine) to allow for urine flow.43 A variety of other units have been used which makes comparisons between different laboratories difficult.43 A rate procedure has recently been described to determine reference ranges for NAG in healthy Chinese adults.46
| Chromogenic tag | Molar extinction coefficient (ε) (L/mol/cm) | Absorbance wavelength (nm) |
|---|---|---|
| 4-Nitrophenyl (ρNP) | 12 800 | 405 |
| 2-Chloro-4-nitrophenyl (CNP) | 3580 | 410-420 |
| Sodio-3,3′-dichlorophenolsulfonphthaleinyl (CPR) | 20 640 | 575 |
| 2-Methoxy-4-(2′-nitrovinyl)-phenyl- (MNP) | 27 000 | 505 |
| 5-[4-(2-Acetamido-2-deoxy-β-D-glucopyranosyloxy)-3-methoxyphenylmethylene]-2-thioxothiazolidin-4-one-3-ethanoate (VRA) | 37 000 | 505 |
| m-Cresolsulphonphthaleinyl- (MCP) | 40 670 | 580 |
NGAL measurements are performed by ELISA or by a chemiluminescent microparticle immunoassay (CMIA). The 2-step CMIA for use on the ARCHITECT analyser developed by Abbots Laboratories was found to be superior to 4 other commercially available assays for urinary NGAL.47 A comparison of this procedure with an ELISA procedure for NGAL48 showed that the level of NGAL in urine varied between the 2 methods and comparison should be carried out with care.
KIM-1 is generally measured by ELISA or a microparticle Luminex xMAP Technology assay, although alternative assays have been developed for measurements in mouse urine. The sensitivity and specificity of ELISA assays are based on the characteristics of the antibody used. Most commercially available KIM-1 assays report comparable sensitivity. However, a meta-analysis published in 2014 reported distinct differences between ELISA and xMAP assays.49
β2-MG has a low molecular weight (11.8 kDa) and, as a result, it is rapidly filtered by the glomerulus and normally 99% is reabsorbed by the tubules. Bernard et al26 developed a highly sensitive procedure for the determination of β2-MG in urine and serum which is based on the direct agglutination of β₂-MG by latex particles containing an antibody. The agglutination is quantified by counting the unagglutinated particles or by using turbidimetry. Data obtained using this procedure compared well with radioimmunoassay procedures (0.97 and 0.93 respectively). A fully automated nephelometric immunoassay to quantify β₂-MG in human serum which is also based on the light scattering signal produced by the agglutination of latex microparticles has been developed.50 An immunoturbidimetric kit for the assay of β₂-MG in urine has also been validated.51
Nephrotoxic Effects of Environmental Pollutants
Environmental pollutants can be defined as elements or compounds introduced into the natural environment potentially causing unfavourable changes. Which do not necessarily cause adverse health effects but may create the environment more likely to result in adverse health effects.
Heavy Metals
Cadmium
Cd is a naturally occurring element and its adverse effect have been monitored in populations exposed to Cd in cigarettes, food and industrial sources. Monitoring the urinary level of this element is recommended as an essential biomarker in environmental studies.52,53 These authors54,55 have discussed the effect of Cd exposure on human health. While diet is the main source of Cd exposure in the general population, smoking also plays an important role and it is now established that smoking is an independent risk factor for renal disease.55
Cd is the seventh most toxic metal (US Agency for Toxic Substances and Disease Registry, ATSDR CAS number 7440-43-9) and remains a major health risk. Exposure to Cd typically results in renal tubulopathy, and a marked reduction in glomerular filtration rate (GFR), which may result in chronic renal failure (CRF).34 Satarug et al55 reviewed the nephrotoxic effect of Cd and Pb in relation to mortality and concluded that the currently accepted tolerable intake of Cd as well as the urinary Cd threshold limit does not provide adequate health protection. A summary of data obtained from epidemiological studies in the US, Spain, Korea, Germany and China indicated supported this conclusion. In view of the known interaction between Cd and Hg environmental exposure to these metals should be kept to a minimum.
The normal route of uptake of Cd is shown in Figure 3. There are several different molecular pathomechanisms behind Cd-induced renal injury which result in tubular dysfunction. These include reabsorption and lysosomal degradation of Cd2+-metallothionein complexes in the proximal and distal tubules, release of free Cd2+, perturbation of cellular Ca2+ homoeostasis, and interference with mitochondrial function.56 The normal route of uptake of Cd is shown in Figure 3.
The severity of Cd-related renal dysfunction is dependent on the level of exposure and the availability of metallothionein. Also important is the presence of other pre-existing adverse health conditions such as diabetes mellitus, as well as age.3,4 The concomitant exposure to other contaminants also has an effect.57 Several studies determined the benchmark dose (BMD) and BMDL (BMD lower confidence limit) values for urinary Cd (UCd). These values have been determined in both Cd-polluted and non-polluted regions in China58 Sweden59 and Thailand.60
After cellular injury, proteins synthesised in the tubular cells may be released and detected in urine. In the case of Cd nephropathy, NAG and KIM-1 have been assayed most frequently.55
It is noteworthy that employees of certain industries, as well as some populations, are especially prone to Cd-elicited tubular nephropathies (Table 1) which is indicated by elevated urinary NAG and other tubular biomarkers. Even low-level environmental Cd and Hg exposure may influence renal tubular function disadvantageously in children.61 The availability of datasets on UCd concentration together with urinary NAG and β2-MG levels were used in the meta-analyses of BMD with a 95% lower confidence limit for UCd.62 Liu et al62 collected 92 datasets from 30 publications. calculated that 1.76 and 1.67 µg/g creatinine were the UCd BMD and BMDL (95%), respectively, at 5% extra risk of benchmark response (BMR). In another meta-analysis based on data from 13 studies,63 3.21 and 2.24 µg/g creatinine UCd, BMD5 and BMDL5 values were derived, respectively. UCd BMD5 and BMDL5 values calculated on the available β2-MG concentrations (3.56 and 3.13 µg/g creatinine, respectively) were comparable to the NAG activity.63 In a recent study64 of males, females and children who had been living in a Cd polluted area for many years found that 2.2 µg/g Cd would be a better threshold for clinical diagnosis. Females were more sensitive to Cd accumulation than males and in the long-term β2-MG was a better biomarker of tubular damage than NAG. In the recent benchmark dose estimation study65 it was found urinary β2-MG and tubular albuminuria were also good biomarkers to assess the nephrotoxic effects of long-term environmental Cd exposures in Chinese women.
Urinary biomarkers, particularly Alb, β2-MG and NAG, were suitable indicators with which to map improving renal function after reduction of dietary Cd-intake in Cd-contaminated areas.66 As a result of the long half-life of Cd in the body67 the deleterious effects of Cd exposure on renal function as indicated by elevated NAG and β2-MG levels are difficult to assess even if low-Cd foods including rice are used. Moriguchi et al68 established that NAG was a more sensitive biomarker for monitoring Cd exposure in the general population than either alpha1-macroglobulin (α1-MG) or β2-MG.
Chronic Cd exposure leading to Itai-Itai disease can also result in osteomalacia and multiple bone fractures in addition to kidney tubular damage. Uchida et al69 found a correlation between urinary levels of vitamin D-binding protein β2-MG, 2 megalin ligands and NAG. Bone mineral loss also correlated with Cd levels and changes in urinary markers in a Cd-exposed female population in Thailand.70 Bone mineral density was also shown to be affected in Chinese women following Cd exposure which also correlated with renal symptoms.71 However, low-level Cd exposure may affect kidney tubules without the involvement of glomeruli and impairment of the bones.72 It is now apparent from the data accumulated from many studies that early monitoring of at-risk populations would be very beneficial.
KIM-1 was shown to be a useful urinary biomarker with which to detect renal tubular injury in Cd-exposed rats.73 It was also demonstrated to be an earlier biomarker of renal tubular dysfunction than NAG and β2-MG in a Cd-exposed population in Thailand.74 These authors demonstrated that KIM-1 correlated with urinary and blood Cd levels as well as with NAG. A positive dose-dependence was recorded between urinary KIM-1 and Cd in both men and women.75 Urinary α1-MG was a sensitive marker of low-level Cd exposure while KIM-1, retinol binding protein (RBP) and possibly Alb were positively associated with urinary Cd only when overnight urine specimens were analysed. No correlation was found with β2-MG.75 The s1 and s2 segments of the early proximal tubule have been identified as the site of damage from Cd exposure, as well as Hg and Pb. However, the emerging role of ZIP8 in mediating the transmembrane movement of a broad range of divalent cations introduces a new dimension. ZIP8, like KIM-1, is expressed in the s3 segment of the proximal tubule.76
Multiple linear regression analyses showed that some type 2 diabetic-related biomarkers are confounders of associations between RBP and Hg or Cd biomarkers.77 Additional data indicated a mediating effect of adiponectin on the relationship between urinary Cd and RBP.77 Analysis of a large cohort from a Cd contaminated district in Thailand found that there was a clear dose-response relationship between urinary KIM-1 and Cd, and that the threshold values of KIM-1 in both genders were less than those of urinary NAG and β2-MG.74 Conflicting results were obtained by Li64 who recommended β2-MG as a better marker for exposure to Cd than NAG in a cohort of 1595 residents living near a contaminated Cd site. Ironworkers using soldering are liable to Cd overload as indicated by higher levels of Cd in blood and urine compared with controls.78 This exposure may lead to kidney damage as indicated by the increase in the level of NAG and β2-MG in urine.
More recently79 it was reported that there were early renal effects of Cd exposure in children and adults living in a tungsten-molybdenum mining area of China. The investigated population studied had significantly higher accumulation of Cd and this was reflected in increasing levels of urinary NAG and β2-MG in children and adults. The principal source of Cd was dietary intake in particular rice.
A recent Korean cross-sectional study considered the effect of exposure to Cd80 on urinary NAG, β2-MG and malondialdehyde (MDA) in adults living in a Cd-polluted area near an abandoned copper refinery. In both the high and low exposure groups urinary Cd levels were positively associated with urinary NAG levels but not with the erum copper to zinc ratio (CZR). After statistical adjustment of the data serum the CZR ratio was strongly associated with urinary β2-MG levels in the low exposure group, and MDA was significantly associated with Cd regardless of Cd exposure. In both high and low Cd exposure groups, the copper-zinc imbalance is a risk factor for renal tubular damage as it induces oxidative stress independent of Cd exposure. Chen et al81 assessed the effects of Cd exposure on serum 25-hydroxyvitamin D {25(OH)D} levels and renal tubular dysfunction in a population environmentally exposed to Cd. β2-MG and RBP were used as indicators of renal dysfunction. Cd exposure did not affect serum 25(OH)D levels and that high 25(OH)D levels were associated with a decreased risk of renal tubular dysfunction. The same group studied the association between Cd exposure and the urinary biomarkers – microalbuminuria, NAG, NAGB isoenzyme, β2-MG and RBP. They reported that the cumulative intake of Cd was lower than the critical standard previously reported suggesting an adverse effect on human health. Because it is difficult to find a population that was exposed exclusively to single metal, Lim et al82 studied the effect of low exposure to Pb and Cd in a large cross-sectional study of the Korean adult population. The concentrations of both Pb and urinary Cd were positively associated with increased excretion of NAG and β2-MG. They found an interactive effect of Pb and Cd exposure on urinary NAG and β2-MG. This study highlighted the potential importance to health of the interactive effect of low-level exposure to multiple heavy metals. Workers in industry where Cd is used are also at risk of adverse effects which have been demonstrated in populations with high industrial and or environmental exposure (Table 2).
| Activity | Reference |
|---|---|
| Workers exposed to Cd pigment dust | Kawada et al83 |
| Welders | Verschoor et al84 |
| Copper-Cd alloy workers | Mason et al85 |
| Nickel-Cd battery manufacturers | Chia et al86 |
| Ore refinery workers | van Sittert et al87 |
| Cd smelters | Lei et al88 |
| Cd plating workers | Kalahasthi et al89 |
| Solderers | Mortada et al78 |
| Residents in Cd contaminated areas | Phuc et al90 and Cui et al79 |
Lead
Renal dysfunctions including tubulopathy have been detected in employees in industries utilising Pb as well as in individuals who have been exposed domestically to Pb paint (Table 3). Pb as well as As are taken up in the s1/s2 segments of the proximal tubule by non-receptor mediated endocytosis (Figure 4). Urinary NAG activity is a sensitive and reliable marker for the detection of kidney tubular injury induced by heavy metals including Pb.91 At the cellular level Pb2+ disturbs Ca2+ homoeostasis in the proximal tubules, which in turn interferes with normal mitochondrial function and elicits apoptotic cell death.56 One explanation of the sensitivity of humans to Pb is the demonstration that õ-aminolevulinic acid dehydratase polymorphism influences the nephrotoxic effect of industrial workers exposed to Pb.92 Metallothionein 1A polymorphism may also influence both urinary uric acid and NAG excretion in lead-exposed workers.93
| Activity | Reference |
|---|---|
| Secondary lead refinery | Endo et al94 |
| Battery plants | Pergande et al95 |
| Lead stabiliser factories | Pergrande et al95 and Lim et al96 |
| Auto garage mechanics | Kumar and Krishnaswamy97 |
| Workers auto repair shops | Oktem et al98 |
| Police exposed to automobile exhaust | Mortada et al99 |
| Residents living nearby a lead battery factory | Lin et al100 |
The nephrotoxic effects of Cd co-contaminants including thallium and antimony should also be considered in Pb-elicited nephrotoxicity in Pb workers.101,102 Pb also increases the nephrotoxic effects of low-level Cd in metal workers,103 however, even low exposure to these heavy metals affects renal function.82 Exposure to Cd and Pb mixtures may also lower blood haemoglobin levels in humans.104 Heavy metal mixtures containing Cd and Pb also cause significant renal dysfunction in residents living in contaminated areas.105 The nephrotoxic effect of Pb exposure and cigarette smoking are synergistic in industrial workers.106 These factors should be considered when planning large-scale occupational epidemiological screening studies. In a study of storage battery plant workers,107 reported that the BMD and BMDL values for blood Pb, based on urinary excretion of total protein, β2-MG and NAG activity were as low as 299.4 and 253.4 µg/L for NAG, underlining the sensitivity of NAG assays. A significant correlation was found between body Pb burden less than 200 µg and 24-hour urine NAG excretion. Other occupational studies gave comparable or even lower values suggesting that renal tubular damage might have preceded Pb-induced osteoporosis.108 Future studies using biomarkers to detect early renal tubular injury caused by occupational Pb exposure should include KIM-1 in addition to NAG.109
Mercury
Hg toxicity continues to be a global health concern.7,110 A significant level of inorganic mercury has been reported in the general population due to its presence in fish, a vapour in dental amalgams, and ethylmercury in vaccines as well as occupationally in gold mining (Table 4). Although traditional methods of measuring exposure using blood and hair levels are useful, intra-population levels vary so that the assay of biomarkers of effect are required. Hg compounds occur as either elementary organic or inorganic Hg compounds.58 Global Hg emissions have grown over the 5 years between 2010 and 2015 at a rate of 1.8% per year from 2188 in 2010 to 2390 metric tonnes in 2015.111 Proximal tubular damage can be extensive following Hg exposure which is linked to the depletion of the thiol pool of the cells and the consequent resulting oxidative stress.56 Increased urinary NAG activity occurs in workers employed in industries where exposure to Hg is low but where exposure lasts for an extended period (Table 4).
The renal tubular changes resulting from exposure to Hg cause physiological and biochemical changes resulting in the release of NAG and other biomarkers. However, these changes can be reversed.119 Increased urinary NAG activity was observed in chlor-alkali plant workers. When selenium concentration was low, changes in urinary NAG activity were detected which were associated with the lower selenium concentrations found in whole blood and serum at an early stage.112 Lower serum glutathione peroxidase activity has also been recorded.113 The titre of autoantibodies against myeloperoxidase was also higher in workers with high Hg exposure. The nephrotoxic effects of Hg exposure and smoking can be synergistic.113 It should be borne in mind that most biomarkers of nephrotoxicity including NAG are general indicators of kidney injury120 and, their correlation with urinary Hg levels is a useful indicator of the extent of tissue damage.
The safety of amalgam fillings is a recurring area of concern. Although they are largely considered safe in the USA, EU and the UK there is a trend away from their use in many countries. The evidence relating to amalgam filling association with nephrotoxicity and urinary NAG levels is ambiguous despite reported associations of elevated urinary NAG levels with amalgam fillings in several studies.121,122 No differences in renal function were found in patients before and after the removal of their amalgam fillings.123 Exposure to Hg vapour did not affect the health of the employees in the dental profession either.124 No effect of amalgam fillings was indicated by urinary NAG activity in children.125 Urinary creatinine levels vary in children due to changes in muscle mass and this should be considered when calculating results. No association was found in a population of Chinese children between urinary NAG and dental amalgam based on historic records of dental treatment. A relationship between NAG activity and urinary Hg level was however found by Mortada et al121 and Ye et al126 Previously, a correlation was found between blood and urine Hg concentrations, the number of fillings and urinary NAG activity and Alb excretion.121 This data suggests that amalgam was not a suitable filling material because of a potential consequence of nephrotoxicity.121 This view was supported by the finding that amalgam fillings probably affect kidney tubular function in children and that urinary NAG values were the most sensitive indicator.122 Oxidative stress may be responsible for tubular damage because urinary NAG and malondialdehyde levels were positively associated.122
In a study of Japanese women urinary NAG and α1-MG levels correlated with dietary intake of fish contaminated with Hg and with the Hg levels found in hair, toenails, and urine.127 Dietary factors, selenium intake and co-exposures to other nephrotoxic agents all influenced urinary Hg and NAG levels in the general population, which had not been exposed occupationally to Hg.112
Arsenic
As is a metalloid and affects millions of people worldwide.9,10 It is one of the most abundant contaminants found in water and soil. A link has been established between its presence and type 2 diabetes and cancer. Epidemiological and experimental studies evaluating As nephrotoxicity have used a combination of biomarkers of nephrotoxicity which included GFR, proteinuria, NAG, β2-MG, α1-MG as well as RBP.128 More recently KIM-1, NGAL and interleukin-18 have also been used to evaluate As nephrotoxicity. The appearance of As in the environment for example in drinking water is typically geological and may cause kidney injury leading to CKD.56 Decrease in the antioxidant capacity of the cells as well as disturbances in mitochondrial function, energy, amino acid and choline metabolism, result in injury to the brush border membrane (Figure 4). In addition to this, apoptotic cell death also occurs in the renal proximal tubules.56
Chronic As exposure increased urinary NAG levels in populations living in areas where As pollution is endemic.129 At a relatively low level As exposure may elicit detectable renal tubular damage.129 Cd exposure may enhance As nephrotoxicity when humans are co-exposed to Cd and As contaminants.130 Cd and As exposure together caused more pronounced renal injury in people living in contaminated areas than in a population exposed to only one of these toxicants.131 Studies of a Korean population co-exposed to Cd, Pb and As from a local abandoned copper smelter, demonstrated that urinary Cd was a risk factor for tubular dysfunction as indicated by elevated urinary NAG levels.132
Long-term exposure to even low concentrations of Cd and/or As may result in tubular damage resulting from oxidative stress indicated by the positive correlation between urinary NAG levels and the oxidative indices urinary malondialdehyde and 8-hydroxy-2′-deoxyguanosine levels.133 Kidney patients exposed to Cd and As present in drinking water and/or in locally produced tobacco, showed higher urinary NAG levels than non-exposed patients.134
As toxicity is complex and involves the generation of free radicals and the induction of oxidative damage to cells. One way of reducing the toxic effect of As is the use of chelating agents, which form inert chelator-metal complexes which can be excreted.135 A cross-sectional study of Mexican children exposed to tap and well water containing As and Cr at levels above the WHO recommended values identified a dose-dependent increase in KIM-1 excretion.5 In a Mexican study of early kidney injury biomarkers including KIM-1 were associated with urinary fluoride but not As levels.136 Environmental hazards from natural sources are widespread, particularly in northern Mexico. A cross-sectional study of children in northern Mexico using renal biomarkers was carried out by Cárdenas-González et al.5 The local tap water had levels of As and Cr which were above the values recommended by the WHO. However, these authors failed to find any increase in functional biomarkers monitored or in miR-21 microRNA and NGAL but did find an increase in KIM-1 (As, Cr) and in miR-200c and miR-423 microRNAs (Cr).
A Sri Lankan study investigated the effect of heavy metals on CKD of unknown aetiology (CKDu). KIM-1 levels correlated with urinary As, Pb and Hg levels but not with Cd level137 while urinary fibrinogen did correlate with urinary As levels. In a systematic review of the association between As, Cd, Pb and chromium in drinking water and CKD, a positive correlation between Cd exposure and urinary NAG and KIM-1 has been reported.138
Silica
Silica (SiO2) is a metalloid oxide of silicon but because silicon dioxide does not contain oxide ions, it has no basic properties. It is, in fact, weakly acidic, reacting with strong bases. A recent study139 demonstrated that mesoporous SiO2 particles (MSNs) have the potential to induce dose-dependent kidney injury in rats. The functional impairment was mediated via MSNs-induced oxidative stress, inflammation, fibrosis and tissue injury. Elevated NAG activity has been recorded in workers exposed to silica in the absence of silicosis.140 An investigation into the possibility of subclinical nephrotoxicity in Egyptian pottery workers by measuring several parameters in the urine of 29 non-smoking and 35 smoking males was undertaken.141 All of the parameters measured were elevated including KIM-1 suggesting that there were subclinical glomerular and tubular effects related to the length and intensity of exposure. In an earlier study, the urine of ceramic workers exposed to SiO2 was compared to matched controls.142 The renal biomarkers Alb, α1-MG, NAG as well as Cu and Zn were measured as well as controls. The data demonstrated that exposure to silica resulted in renal changes which correlated with the level of exposure. A recent study by Ramadan et al143 demonstrated that urinary liver-type fatty acid-binding protein (L-FABP) may also be used to screen for renal injuries in silica dust exposed handicraft pottery workers.
In Taiwan, KIM-1 and NGAL were significantly elevated in welding workers post-exposure to metal fumes, as were urinary Al, Cr, Mn, Fe, Co and Ni levels. The level of NGAL was more significantly associated with Al (r = .737, P < .001), Cr (r = .705, P < .001), Fe (r = .709, P < .001) and Ni (r = .657, P < .001) than KIM-1. This suggests that NGAL may be a urinary biomarker for PM2.5 exposure in welding workers.144 In the light of these results the future application of NGAL in screening the nephrotoxic for the effect of high-metal content, fumes and dust has promise.
Conclusions
The exposure of at-risk populations to heavy metals is still a major problem. Recent changes in technology involving metals and the sensitivity of the kidney to them have added to the urgency to utilise established as well as to develop additional sensitive biomarkers. Each year the world produces in the region of 50 million tonnes of electronic waste (e-waste). The e-waste contains potentially harmful materials such as Cd, Hg and Pb. It is therefore becoming more important to monitor the health of people who are exposed to e-waste. Cd is one of the candidates responsible for the devastating increase in CKD in Sri Lanka, again emphasising the need for inexpensive and sensitive biomarkers for screening the affected populations. Estimated global Hg emissions increased 20% between 2010 and 2015. The WHO estimates that more than 200 million people worldwide are chronically exposed to unsafe levels of As in drinking water. Since exposure to environmental toxins can be monitored, progression to kidney disease is preventable. Biomarkers can therefore play an important role in this field. The first 2 decades of the 21st century have seen an accumulation of evidence for NAG and/or β2-MG as the biomarkers of choice in many situations. Although β2-MG is still widely used its stability raises problems for its use in large population studies and these need to be considered. β2-MG may, in fact, be a better marker for glomerular rather than tubular pathology. The introduction of functional biomarkers such as NGAL and markers of distinct areas of the tubule such as KIM-1 offers greater qualitative measures of pollutant-induced nephrotoxicity. NAG is still the predominant biomarker used in the environmental field but the availability of KIM-1 and NGAL has added the potential to be able to monitor both the severity and progression of any nephrotoxic effect.
Ethical Approval and Informed Consent
Where appropriate ethical approval and informed consent were obtained by the authors of each review or publication quoted in this article.
Declaration of Conflicting Interests:
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The publication was supported in Debecen (IP) by the GINOP-2.3,2-15-2016-00062 project co-financed by the European Union and the regional Development Fund. The publication was supported through funding from The Kidney Fund, The Tom and Sheila Springer Trust, Epsom and St. Helier University Hospitals NHS Trust and Kidney Research (MD) and UK and the European Union STEP research programme (RGP).
ORCID iD
Robert G Price https://orcid.org/0000-0001-8551-0349
Footnote
Literature Search Procedure In the preparation of this review the literature was searched using PubMed, Biological Abstracts and various WHO publications for the terms nephrotoxicity, biomarkers, urinary enzymes, NAG, KIM-1, NGAL, β2-MG, heavy metals, Cd, Hg, Pb, As and silica together with the phrase various contaminants.
References
1. The Global E-waste Monitor 2020. Accessed September 8, 2021. http://ewastemonitor.info.
2. Xu X, Nie S, Ding H, Hou FF. Environmental pollution and kidney diseases. Nat Rev Nephrol. 2018;14:313-324.
3. Li HB, Li M-Y, Zhao D, et al. Oral bioavailability of As, Pb, and Cd in contaminated soils, dust, and foods based on animal bioassays: a review. Environ Sci Technol. 2019;53:10545-10559.
4. Zhao D, Wang JY, Tang N, et al. Coupling bioavailability and stable isotope ratio to discern dietary and non-dietary contribution of metal exposure to residents in mining-impacted areas. Environ Int. 2018;120:563-571.
5. Cárdenas-González M, Osorio-Yáñez C, Gaspar-Ramírez O, et al. Environmental exposure to arsenic and chromium in children is associated with kidney; injury molecule-1. Environ Res. 2016;150:653-662.
6. World Health Organisation (WHO). An estimated 12.6-million deaths each year are attributable to unhealthy environments. 2016. Accessed November 12, 2020. https://www.who.int/news/item/15-03-2016.
7. UN Environment Global Mercury Assessment. UN Environment Programme Chemicals and Health Branch Geneva, Switzerland. 2018. https://www.unep.org/resources/publication/global-mercury-assessment-2018.
8. Khan EA, Abbas Z. A scoping review of sources of mercury and its health effects among Pakistan’s most vulnerable population. Rev Environ Health. 2021;36:39-45.
9. Arsenic, WHO, Health Topics, Newsroom. 2018. https://www.who.int/news-room/fact-sheets/detail/arsenic#:~:text=It%20is%20now%20recognized%20that,well%2Dwater%20in%20that%20country
10. Kuivenhoven M, Mason K. Arsenic toxicity. In: StatPearls (Internet). StatPearls Publishing; 2021:1–25.
11. Kathuria P. Lead nephropathy. eMedicine 2019; Accessed July 9, 2020. https://emedicine.com/article/242605-overview
12. Reyes JL, Molina-Jijón E, Rodríguez-Muñoz R, Bautista-García P, Debray-García Y, Namorado Mdel C. Tight junction proteins and oxidative stress in heavy metals-induced nephrotoxicity. Biomed Res Int. 2013;2013:730789.
13. Lentini P, Zanoli L, Granata A, Signorelli SS, Castellino P, Dell’Aquila R. Kidney and heavy metals - the role of environmental exposure (Review). Mol Med Rep. 2017;15:3413-3419.
14. Frank JJ, Poulakos AG, Tornero-Velez R, Xue J. Systematic review and meta-analyses of lead (Pb) concentrations in environmental media (soil, dust, water, food, and air) reported in the United States from 1996 to 2016. Sci Total Environ. 2019;694:133489.
15. Fuchs TC, Hewitt P. Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology. AAPS J. 2011;13:615-631.
16. Schiffl H, Lang SM. Update on biomarkers of acute kidney injury: moving closer to clinical impact? Mol Diagn Ther. 2012;16:199-207.
17. Bonventre JV. Current biomarkers in kidney disease. Dawning of a new era. ASN Kidney News. 2014;6:7-8.
18. Wasung ME, Chawla LS, Madero M. Biomarkers of renal function, which and when? Clin Chim Acta. 2015;438:350-357.
19. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant. 2013;28:254-273.
20. Donaldson MD, Chambers RE, Woolridge MW, Whicher JT. Stability of alpha1-microglobulin, beta2-microglobulin and retinol binding protein in urine. Clin Chim Acta. 1989;179:73-77.
21. Le JM, Han YH, Choi SJ, et al. Variation of nephrotoxicity biomarkers by urinary storage condition in rats. Toxicol Res. 2014;30:305-309.
22. Zeng X, Hossain D, Bostwick DG, Herrera GA, Zhang PL. Urinary β2-microglobulin is a good indicator of proximal tubule injury: a correlative study with renal biopsies. J Biomark. 2014;2014:492838.
23. Schardijn G, Statius van Eps LW, Swaak AJ, Kager JC, Persijn JP. Urinary beta2 microglobulin in upper and lower urinary-tract infections. Lancet. 1979;1:805-807.
24. Hofstra JM, Deegens JK, Willems HL, Wetzels JF. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant. 2008;23:2546-2551.
25. Davey PG, Gosling P. Beta 2-microglobulin instability in pathological urine. Clin Chem. 1982;28:1330-1333.
26. Bernard AM, Moreau D, Lauwerys R. Comparison of retinol-binding protein and β2-microglobulin determination in urine for the early detection of tubular proteinuria. Clin Chim Acta. 1982;126:1-7.
27. Nishida M, Kawakatsu H, Komatsu H, et al. Values for urinary β-microglobulin and N-acetyl-β-D-glucosaminidase in normal healthy infants. Acta Paediatr Jpn. 1998;40:424-426.
28. Lai HC, Chang SN, Lin HC, et al. Association between urine pH and common uropathogens in children with urinary tract infections. J Microbiol Immunol Infect. 2021;54:290-298.
29. Argyropoulos CP, Chen SS, Ng YH, et al. Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases. Front Med. 2017;4:73.
30. Johri N, Jacquillet G, Unwin R. Heavy metal poisoning: the effects of cadmium on the kidney. Biometals. 2010;23:783-792.
31. Thévenod F, Lee WK. Live and let die: roles of autophagy in cadmium nephrotoxicity. Toxics. 2015;3:130-151.
32. Price RG. Urinary enzymes, nephrotoxicity and renal disease. Toxicology. 1982;23:99-134.
33. Price RG. Measurement of N-acetyl-beta-glucosaminidase and its isoenzymes in urine methods and clinical applications. Eur J Clin Chem Clin Biochem. 1992;30:693-705. 1493161.
34. Satarug S. Dietary cadmium intake and its effects on kidneys. Toxics. 2018;6:15.
35. Hosohata K, Jin D, Takai S, Iwanaga K. Involvement of vanin-1 in ameliorating effect of oxidative renal tubular injury in Dahl-salt sensitive rats. Int J Mol Sci. 2019;20:4481.
36. Nakatani S, Nakatani A, Ishimura E, et al. Urinary iron excretion is associated with urinary full-length megalin and renal oxidative stress in chronic kidney disease. Kidney Blood Press Res. 2018;43:458-470.
37. Song J, Yu J, Prayogo GW, et al. Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology. Am J Transl Res. 2019;11:1219-1229.
38. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med. 2010;4:265-280.
39. Cabral M, Toure A, Garçon G, et al. Effects of environmental cadmium and lead exposure on adults neighboring a discharge: evidences of adverse health effects. Environ Pollut. 2015;206:247-255.
40. Zhang Y-R, Wang P, Liang X-X, et al. Associations between urinary excretion of cadmium and renal biomarkers in nonsmoking females: a cross-sectional study in rural areas of South China. Int J Environ Res Public Health. 2015;12:11988-12001.
41. Schraml E, Hackl M, Grillari J. MicroRNAs and toxicology: a love marriage. Toxicol Rep. 2017;4:634-636.
42. Harrill AH, Sanders A. Urinary microRNAs in environmental health: biomarkers of emergent kidney injury and disease. Curr Environ Health Rep. 2020;7:101-108.
43. Csáthy L, Pócsi I. Urinary N-acetyl-β-D glucoasminidase in newborns and children: methods and diagnostic applications. Eur J Clin Chem Clin Biochem. 1995;9:575-587.
44. Pócsi I, Taylor SA, Richardson AC, Aamlid KH, Smith BV, Price RG. “VRA-glcnac”: novel substrate for N-acetyl-beta-D-glucosaminidase applied to assay of this enzyme in urine. Clin Chem. 1990;36:1884-1888.
45. Yuen CT, Kind PR, Price RG, Praill PF, Richardson AC. Colorimetric assay for N-acetyl-beta-D-glucosaminidase (NAG) in pathological urine using the omega-nitrostyryl substrate: the development of a kit and the comparison of manual procedure with the automated fluorimetric method. Ann Clin Biochem. 1984;21(Pt 4):295-300.
46. Liu Q, Zong R, Li H, et al. Distribution of urinary N-acetyl-beta-D-glucosaminidase and the establishment of reference intervals in healthy adults. J Clin Lab Anal. 2021;35:e23748.
47. Kift RL, Messenger MP, Wind TC, et al. A comparison of the analytical performance of five commercially available assays for neutrophil gelatinase-associated lipocalin using urine. Ann Clin Biochem. 2013;50:236-244.
48. Krzeminska E, Wyczalkowska-Tomasik A, Korytowska N, Paczek L. Comparison of two methods for determination of NGAL levels in urine: ELISA and CMIA. J Clin Lab Anal. 2016;30:956-960.
49. Shao X, Tian L, Xu W, et al. Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis. PLoS One. 2014;9:e84131.
50. Viedma JA, Pacheco S, Albaladejo MD. Determination of β2-microglobulin in serum by a microparticle-enhanced nephelometric immunoassay. Clin Chem. 1992;38:2464-2468.
51. Chan PC, Kulasingam V, Lem-Ragosnig B. Validating urinary measurement of beta-2-microglobulin with a Roche reagent kit designed for serum measurements. Clin Biochem. 2012;45:1533-1635.
52. Vacchi-Suzzi C, Kruse D, Harrington J, et al. Is urinary cadmium a biomarker of long-term exposure in humans? A review. Curr Environ Health Rep. 2016;3:450-458.
53. Nordberg GF, Bernard A, Diamond GL, et al. Risk assessment of effects of cadmium on human health (IUPAC Technical Report). Pure Appl Chem. 2018;90:755-808.
54. Price RG. Cadmium nephropathy and smoking. Clin Med Insights Urol. 2017;10:1-8.
55. Satarug S, Gobe CG, A Vesey D, Phelps KR. Cadmium and lead exposure, nephrotoxicity, and mortality. Toxics. 2020;8:86.
56. Rana MN, Tangpong J, Rahman MM. Toxicodynamics of lead, cadmium, mercury and arsenic- induced kidney toxicity and treatment strategy: a mini review. Toxicol Rep. 2018;5:704-713.
57. Nordberg GF. Historical perspectives on cadmium toxicology. Toxicol Appl Pharmacol. 2009;238:192-200.
58. Sun M, Wang T, Xu X, Zhang L, Li J, Shi Y. Ecological risk assessment of soil cadmium in China’s coastal economic development zone: a meta-analysis. Ecosyst Health Sustain. 2020;6:17733921.
59. Wallin M, Sallsten G, Fabricius-Lagging E, Öhrn C, Lundh T, Barregard L. Kidney cadmium levels and associations with urinary calcium and bone mineral density: a cross-sectional study in Sweden. Environ Health. 2013;12:22.
60. Nishijo M, Suwazono Y, Ruangyuttikarn W, et al. Risk assessment for Thai population: benchmark dose of urinary and blood cadmium levels for renal effects by hybrid approach of inhabitants living in polluted and non-polluted areas in Thailand. BMC Public Health. 2014;14:702.
61. de Burbure C, Buchet J-P, Leroyer A, et al. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect. 2006;114:584-590.
62. Liu C, Li Y, Zhu C, et al. Benchmark dose for cadmium exposure and elevated N-acetyl-β-D-glucosaminidase: a meta-analysis. Environ Sci Pollut Res. 2016;23:20528-20538.
63. Woo HD, Chiu WA, Jo S, Kim J. Benchmark dose for urinary cadmium based on a marker of renal dysfunction: a meta-analysis. PLoS One. 2015;10:e0126680.
64. Li Y, Wang H, Yu J, et al. An assessment of sensitivity biomarkers for urinary cadmium burden. BMC Nephrol. 2020;21:385.
65. Yan J, Huo J, Li R, et al. Benchmark dose estimation of urinary and blood cadmium as biomarkers of renal dysfunction among 40-75-year-old non-smoking women in rural areas of southwest China. J App Toxicol. 2019;39:1433-1443.
66. Liang Y, Lei L, Nilsson J, et al. Renal function after reduction in cadmium exposure: an 8-year follow-up of residents in cadmium-polluted areas. Environ Health Perspect. 2012;120:223-228.
67. Huang L, Liu L, Zhang T, et al. An interventional study of rice for reducing cadmium exposure in a Chinese industrial town. Environ Int. 2018;122:301-309.
68. Moriguchi J, Inoue Y, Kamiyama S, et al. N-acetyl-β-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas. Toxicol Lett. 2009;190:1-8.
69. Uchida M, Teranishi H, Aoshima K, Katoh T, Kasuya M, Inadera H. Elevated urinary levels of vitamin D-binding protein in the inhabitants of a cadmium polluted area, Jinzu River basin, Japan. Tohoku J Exp Med. 2007;211:269-274.
70. Limpatanachote P, Swaddiwudhipong W, Nishijo, et al. Cadmium-exposed population in Mae Sot District, Tak Province: 4 bone mineral density in persons with high cadmium exposure. J Med Assoc Thai. 2010;93:1451-1457.
71. Chen X, Zhu G, Jin T, Wang Z. Effects of cadmium on bone mineral density in the distal and proximal forearm: two female population studies in China. Biol Trace Elem Res. 2013;156:45-48.
72. Eom S-Y, Seo MN, Lee Y-S, et al. Low-level environmental cadmium exposure induces kidney tubule damage in the general population of Korean adults. Arch Environ Contam Toxicol. 2017;73:401-409.
73. Prozialeck WC, Edwards JR. Early biomarkers of cadmium exposure and nephrotoxicity. Biometals. 2010;23:793-809.
74. Ruangyuttikarn W, Panyamoon A, Nambunmee K, Honda R, Swaddiwudhipong W, Nishijo M. Use of the kidney injury molecule-1 as a biomarker for early detection of renal tubular dysfunction in a population chronically exposed to cadmium in the environment. Springerplus. 2013;2:533.
75. Wallin M, Sallsten G, Lundh T, Barregard L. Low-level cadmium exposure and effects on kidney function. Occup Environ Med. 2014;71:848-854.
76. Fujishiro H, Yano Y, Takada Y, Tanihara M, Himeno S. Roles of ZIP8, ZIP14, and DMT1 in transport of cadmium and manganese in mouse kidney proximal tubule cells. Metallomics. 2012;4:700-708.
77. Valcke M, Ouellet N, Dubé M, et al. Biomarkers of cadmium, lead and mercury exposure in relation with early biomarkers of renal dysfunction and diabetes: results from a pilot study among aging Canadians. Toxicol Lett. 2019;312:148-156.
78. Mortada WI, Hassanien MM, Donia AF, Shokeir AA. Application of cloud point extraction for cadmium in biological samples of occupationally exposed workers: relation between cadmium exposure and renal lesion. Biol Trace Elem Res. 2015;168:303-310.
79. Cui X, Cheng H, Liu X, et al. Cadmium exposure and early renal effects in the children and adults living in a tungsten-molybdenum mining areas of South China. Environ Sci Pollut Res Int. 2018;25:15089-15101.
80. Eom S-Y, Yim D-H, Huang M, et al. Copper–zinc imbalance induces kidney tubule damage and oxidative stress in a population exposed to chronic environmental cadmium. Int Arch Occupat Health. 2020;93:337-344.
81. Chen X, Dai Y, Wang Z, Zhu G, Ding X, Jin T. The association between serum vitamin D levels and renal tubular dysfunction in a general population exposed to cadmium in China. PLoS One. 2018;13:e0195682.
82. Lim H, Lim JA, Choi JH, et al. Associations of low environmental exposure to multiple metals with renal tubular impairment in Korean adults. Toxicol Res. 2016;32:57-64.
83. Kawada T, Shinmyo RR, Suzuki S. Urinary cadmium and N-acetyl-beta-D-glucosaminidase excretion of inhabitants living in a cadmium-polluted area. Int Arch Occup Environ Health. 1992;63:541-546.
84. Verschoor M, Herber R, van Hemmen J, Wibowo A, Zielhuis R. Renal function of workers with low-level cadmium exposure. Scand J Work Environ Health. 1987;13:232-238.
85. Mason HJ, Davison AG, Wright AL, et al. Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers. Brit J Ind Med. 1988;45:793-802.
86. Chia KS, Ong CN, Ong HY, Endo G. Renal tubular function of workers exposed to low levels of cadmium. Brit J Ind Med. 1989;46:165-170.
87. van Sittert NJ, Ribbens PH, Huisman B, Lugtenburg D. A nine year follow up study of renal effects in workers exposed to cadmium in a zinc ore refinery. Br J Ind Med. 1993;50:603-612.
88. Lei LJ, Chen L, Jin TY, Nordberg M, Chang XL. Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters. Toxicol Sci. 2007;97:189-195.
89. Kalahasthi RB, Rajmohan H, Rajan B, Kumar MK. Urinary N-acetyl-beta-D-glucosaminidase and its isoenzymes A & B in workers exposed to cadmium at cadmium plating. J Occup Med Toxicol. 2007;2:5.
90. Phuc HD, Kido T, Oanh NTP, et al. Effects of aging on cadmium concentrations and renal dysfunction in inhabitants in cadmium-polluted regions in Japan. J Appl Toxicol. 2017;37:1046-1052.
91. dos Santos AC, Colacciopo S, Dal Bó CM, dos Santos NA. Occupational exposure to lead, kidney function tests, and blood pressure. Am J Ind Med. 1994;26:635-643.
92. Tian L, Zheng G, Sommar JN, et al. Lead concentration in plasma as a biomarker of exposure and risk, and modification of toxicity by δ-aminolevulinic acid dehydratase gene polymorphism. Toxicol Lett. 2013;221:102-109.
93. Yang CC, Chen HI, Chiu YW, Tsai CH, Chuang HY. Metallothionein 1A polymorphisms may influence urine uric acid and N-acetyl-beta-D-glucosaminidase (NAG) excretion in chronic lead-exposed workers. Toxicology. 2013;306:68-73.
94. Endo G, Horiguchi S, Kiyota I. Urinary N-acetyl-beta-D-glucosaminidase activity in lead-exposed workers. J Appl Toxicol. 1990;10:235-238.
95. Pergande M, Jung K, Precht S, Fels LM, Herbort C, Stolte H. Changed excretion of urinary proteins and enzymes by chronic exposure to lead. Nephrol Dial Transplant. 1994;9:613-618.
96. Lim YC, Chia KS, Ong HY, Ng V, Chew YL. Renal dysfunction in workers exposed to inorganic lead. Ann Acad Med Singap. 2001;30:112-117.
97. Kumar BD, Krishnaswamy K. Detection of occupational lead nephropathy using early renal markers. J Toxicol Clin Toxicol. 1995;33:331-335.
98. Oktem F, Arslan MK, Dündar B, Delibas N, Gültepe M, Ergürhan Ilhan I. Renal effects and erythrocyte oxidative stress in long-term low-level lead-exposed adolescent workers in auto repair workshops. Arch Toxicol. 2004;78:681-687.
99. Mortada WI, Sobh MA, El-Defrawy MM, Farahat SE. Study of lead exposure from automobile exhaust as a risk for nephrotoxicity among traffic policemen. Am J Nephrol. 2001;21:274-279.
100. Lin JL, Yeh KH, Tseng HC, Chen WY, Lai HH, Lin YC. Urinary N-acetyl-glucosaminidase excretion and environmental lead exposure. Green Cross Health Service Association Study Group. Am J Nephrol. 1993;13:442-447.
101. Weaver VM, Kim NS, Jaar BG, et al. Associations of low-level urine cadmium with kidney function in lead workers. Occup Environ Med. 2010;68:250-256.
102. Shelley R, Kim NS, Parsons P, et al. Associations of multiple metals with kidney outcomes in lead workers. Occup Environ Med. 2012;69:727-735.
103. Hambach R, Lison D, D’Haese PC, et al. Co-exposure to lead increases the renal response to low levels of cadmium in metallurgy workers. Toxicol Lett. 2013;222:233-238.
104. Chen X, Zhou H, Li X, Wang Z, Zhu G, Jin T. Effects of lead and cadmium co-exposure on hemoglobin in a Chinese population. Environ Toxicol Pharmacol. 2015;39:758-763.
105. Qian Y, Chen C, Zhang Q, Li Y, Chen Z, Li M. Concentrations of cadmium, lead, mercury and arsenic in Chinese market milled rice and associated population health risk. Food Control. 2010;21:1757-1763.
106. EL-Safty IA, Afifi AM, Shouman AE, EL-Sady AK. Effects of smoking and lead exposure on proximal tubular integrity among Egyptian industrial workers. Arch Med Res. 2004;35:59-65.
107. Lin T, Tai-Yi J. Benchmark dose approach for renal dysfunction in workers exposed to lead. Environ Toxicol. 2007;22:229-233.
108. Sun Y, Sun D, Zhou Z, et al. Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead. Ann Occup Hyg. 2008;52:527-533.
109. Zhou R, Xu Y, Shen J, et al. Urinary KIM-1: a novel biomarker for evaluation of occupational exposure to lead. Sci Rep. 2016;6:38930.
110. Branco V, Caito S, Farina M, Teixeira da, Rocha J, Aschner M, Carvalho C. Biomarkers of mercury toxicity: past, present, and future trends. J Toxicol Environ Health B Crit Rev. 2017;20:119-154.
111. Streets DG, Horowitz HM, Lu Z, Levin L, Thackray CP, Sunderland EM. Global and regional trends in mercury emissions and concentrations, 2010–2015. Atmos Environ. 2019;201:417-427.
112. Jarosińska D, Horvat M, Sällsten G, et al. Urinary mercury and biomarkers of early renal dysfunction in environmentally and occupationally exposed adults: a three-country study. Environ Res. 2008;108:224-232.
113. El-Safty IAM, Shouman AE, Amin NE. Nephrotoxic effects of mercury exposure and smoking among Egyptian workers in a fluorescent lamp factory. Arch Med Res. 2003;34:50-55.
114. Rosenman KD, Valciukas JA, Glickman L, Meyers BR, Cinotti A. Sensitive indicators of inorganic mercury toxicity. Arch Environ Health. 1986;41:208-215.
115. Ehrenberg RL, Vogt RL, Smith AB, et al. Effects of elemental mercury exposure at a thermometer plant. Am J Ind Med. 1991;19:495-507.
116. Boogaard PJ, Houtsma AT, Journée HL, Van Sittert NJ. Effects of exposure to elemental mercury on the nervous system and the kidneys of workers producing natural gas. Arch Environ Health. 1996;51:108-115.
117. Kobal AB, Flisar Z, Miklavčiè V, et al. Renal function in miners intermittently exposed to elemental mercury vapour. Arch Hig Rada Toksikol. 2000;51:369-380.
118. Drake PL, Rojas M, Reh CM, Mueller CA, Jenkins FM. Occupational exposure to airborne mercury during gold mining operations near El Callao, Venezuela. Int Arch Occup Environ Health. 2001;74:206-212.
119. Efskind J, Ellingsen DG, Hartman A, et al. Renal function of chloralkali workers after the cessation of exposure to mercury vapor. Scand J Work Environ Health. 2006;32:241-249.
120. Nuttall KL. Interpreting mercury in blood and urine of individual patients. Ann Clin Lab Sci. 2004;34:235-250.
121. Mortada WL, Sobh MA, El-Defrawy M-M, Farahat SE. Mercury in dental restoration: is there a risk of nephrotoxicity? J Nephrol. 2002;15:171-176.
122. Al-Saleh I, Al-Sedairi AA, Elkhatib R. Effect of mercury (Hg) dental amalgam fillings on renal and oxidative stress biomarkers in children. Sci Total Environ. 2012;431:188-196.
123. Sandborgh-Englund G, Nygren AT, Ekstrand J, Elinder CG. No evidence of renal toxicity from amalgam fillings. Am J Physiol. 1996;271:R941-R945.
124. Langworth S, Sällsten G, Barregård L, Cynkier I, Lind ML, Söderman E. Exposure to mercury vapor and impact on health in the dental profession in Sweden. J Dent Res. 1997;76:1397-1404.
125. Barregard L, Trachtenberg F, McKinlay S. Renal effects of dental amalgam in children: the New England children’s amalgam trial. Environ Health Perspect. 2008;116:394-399.
126. Ye X, Qian H, Xu P, Zhu L, Longnecker MP, Fu H. Nephrotoxicity, neurotoxicity and mercury exposure among children with and without dental amalgam fillings. Int J Hyg Environ Health. 2009;212:378-386.
127. Ohno T, Sakamoto M, Kurosawa T, Dakeishi M, Iwata T, Murata K. Total mercury levels in hair, toenail, and urine among women free from occupational exposure and their relations to renal tubular function. Environ Res. 2007;103:191-197.
128. Robles-Osorio ML, Sabath-Silva E, Sabath E. Arsenic-mediated nephrotoxicity. Ren Fail. 2015;37:542-547.
129. Eom SY, Lee YC, Yim DH, et al. Effects of low-level arsenic exposure on urinary N-acetyl-β-D-glucosaminidase activity. Hum Exp Toxicol. 2011;30:1885-1891.
130. Hong F, Jin T, Zhang A. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. Biometals. 2004;17:573-580.
131. Nordberg GF. Biomarkers of exposure, effects and susceptibility in humans and their application in studies of interactions among metals in China. Toxicol Lett. 2010;192:45-49.
132. Kim YD, Eom SY, Yim DH, et al. Environmental exposure to arsenic, lead, and cadmium in people living near Janghang copper smelter in Korea. J Korean Med Sci. 2016;31:489-496.
133. Huang M, Choi SJ, Kim DW, et al. Risk assessment of low-level cadmium and arsenic on the kidney. J Toxicol Environ Health A. 2009;72:1493-1498.
134. Arain MB, Kazi TG, Baig JA, et al. Co-exposure of arsenic and cadmium through drinking water and tobacco smoking: risk assessment on kidney dysfunction. Environ Sci Pollut Res Int. 2015;22:350-357.
135. Bjørklund G, Oliinyk P, Lysiuk R, et al. Arsenic intoxication: general aspects and chelating agents. Arch Toxicol. 2020;94:1879-1897.
136. Jiménez-Córdova MI, Cárdenas-González M, Aguilar-Madrid G, et al. Evaluation of kidney injury biomarkers in an adult Mexican population environmentally exposed to fluoride and low arsenic levels. Toxicol Appl Pharmacol. 2018;352:97-106.
137. Wanigasuriya K, Jayawardene I, Amarasiriwardena C, Wickremasinghe R. Novel urinary biomarkers and their association with urinary heavy metals in chronic kidney disease of unknown aetiology in Sri Lanka: a pilot study. Ceylon Med J. 2017;62:210-217.
138. Farkhondeh T, Naseri K, Esform A, Aramjoo H, Naghizadeh A. Drinking water heavy metal toxicity and chronic kidney diseases: a systematic review. Rev Environ Health. 2021;36:359-366.
139. Mahmoud AM, Desouky EM, Hozayen WG, et al. Mesoporous silica nanoparticles trigger liver and kidney injury and fibrosis via altering TLR4/NF-κB, JAK2/STAT3 and Nrf2/ho-1 signaling in rats. Biomolecules. 2019;9:528.
140. Hotz P, Gonzalez-Lorenzo J, Siles E, Trujillano G, Lauwerys R, Bernard A. Subclinical signs of kidney dysfunction following short exposure to silica in the absence of silicosis. Nephron. 1995;70:438-442.
141. Mourad BH, Ashour YA. Demonstration of subclinical early nephrotoxicity induced by occupational exposure to silica among workers in pottery industry. Int J Occup Environ Med. 2020;11:85-94.
142. Ibrahim KS, Ahmed SB, Amer NM. Study of kidney dysfunction in non-silicotic Egyptian workers. Int J Hyg Environ Health. 2011;214:53-58.
143. Ramadan MA, Abdelgwad M, Fouad MM. Predictive value of novel biomarkers for chronic kidney disease among workers occupationally exposed to silica. Toxicol Ind Health. 2021;37:173-181.
144. Chuang KJ, Pan CH, Su CL, et al. Urinary neutrophil gelatinase-associated lipocalin is associated with heavy metal exposure in welding workers. Sci Rep. 2015;5:18048.
Supplementary Material
Please find the following supplemental material visualised and available to download via Figshare in the display box below. Where there are more than one item, you can scroll through each tab to see each separate item.
Please note all supplemental material carries the same license as the article it is here associated with
Summary
Supplemental material for this article is available online.
Resources
File (sj-docx-1-bmi-10.1177_11772719221111882.docx)
- Download
- 32.84 KB
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: July 14, 2022
Issue published: January-December 2022
Keywords
Rights and permissions
© The Author(s) 2022.
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Request permissions for this article.
PubMed: 35859925
Authors
Metrics and citations
Metrics
Article usage*
Total views and downloads: 1435
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 12 view articles Opens in new tab
Crossref: 6
- First report on the toxicity of SARS-CoV-2, alone and in combination w...
- Low level mancozeb exposure causes copper bioaccumulation in the renal...
- New perspectives in application of kidney biomarkers in mycotoxin indu...
- Structural Characterization of Toxicologically Relevant Cd2+-L-Cystein...
- The NOAEL Equivalent of Environmental Cadmium Exposure Associated with...
- Multiple Targets of Toxicity in Environmental Exposure to Low-Dose Cad...
Figures and tables
Figures & Media
Tables
View Options
View options
PDF/ePub
View PDF/ePubGet access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
Alternatively, view purchase options below:
Access journal content via a DeepDyve subscription or find out more about this option.
